| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.1M | +89.8% |
| Cost of Revenue | $11.6M | +53.4% |
| Gross Profit | $4.5M | +394.1% |
| R&D Expense | $1.5M | -32.8% |
| SG&A Expense | $21.5M | +46.8% |
| Operating Income | -$18.8M | -21.6% |
| Pre-tax Income | -$19.4M | -19.7% |
| Net Income | -$19.4M | -19.7% |
| EPS (Basic) | -$3.16 | +45.9% |
| EPS (Diluted) | -$3.16 | +45.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | +21.8% |
| Accounts Receivable | $504K | +1083.3% |
| Inventory | $9.5M | +83.6% |
| Current Assets | $16.8M | +60.2% |
| Total Assets | $30.7M | +19.3% |
| Current Liabilities | $6.7M | +112.0% |
| Long-term Debt | $2.7M | -49.2% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.3M | -70.8% |
| Capital Expenditures | $789K | +49.5% |
| Investing Cash Flow | -$1.1M | -111.9% |
| Financing Cash Flow | $19.5M | +60.0% |
| Free Cash Flow | -$18.1M | -69.7% |
| $7.8M |
| -5.8% |
| Stockholders' Equity | $22.9M | +31.4% |